GenoScreen Overview

  • Founded
  • 2001
  • Status
  • Private
  • Employees
  • 44
  • Latest Deal Type
  • Angel
  • Latest Deal Amount
  • $1.14M
Latest Deal Amount
  • Investors
  • 3

GenoScreen General Information


Developer and supplier of innovative genomics services and products designed to meet life science performance needs. The company's genomics services and products gene sequencing, genotyping, bioinformatics, preparation of genetic material and typing of microorganisms, based on new sequencing and mass genotyping technologies, enabling health, agro-food and environmental sectors to get a broad set of services

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Industries
Other Pharmaceuticals and Biotechnology
Primary Office
  • 1 rue du Professeur Calmette
  • 59000 Lille
  • France
+33 03 00 00 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

GenoScreen Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Angel (individual) 28-Jan-2019 $1.14M 00.000 00.00 Completed Generating Revenue
5. Secondary Transaction - Private 00000 Completed Generating Revenue
4. Grant 01-Feb-2011 000.00 00000 Completed Generating Revenue
3. Later Stage VC 26-Mar-2010 00000 00000 00.000 Completed Generating Revenue
2. Early Stage VC 01-Jan-2005 Completed Generating Revenue
1. Early Stage VC 01-Sep-2002 Completed Startup
To view GenoScreen’s complete valuation and funding history, request access »

GenoScreen Cap Table

Stock # of Shares
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Class B 000 0000.000000 00000.0 000000000.00 000000 00000.0 00.000
A Preference 000 0000.000000 0000.00 0000.00 00 0000.00 0.000
Ordinary 412 $114.129107 $691.62 $691.62 1x $691.62 10.57%
To view GenoScreen’s complete cap table history, request access »

GenoScreen Executive Team (2)

Name Title Board Seat Contact Info
André Tordeux Co-Founder, Chairman, Chief Executive Officer & President
Philippe Amouyel Co-Founder
To view GenoScreen’s complete executive team members history, request access »

GenoScreen Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

GenoScreen Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Grand Emprunt National Corporation 000 0000 000000 0
Finorpa Venture Capital Minority 000 0000 000000 0
Finovam Gestion Venture Capital Minority 000 0000 000000 0
To view GenoScreen’s complete investors history, request access »